Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The endovenous ablation devices market was valued at USD 1.12 Billion in 2025. It is poised to grow at a CAGR of 10.20% during the forecast period of 2026-2035, and reach USD 2.96 Billion by 2035. The market growth is driven by the rising prevalence of varicose veins and chronic venous insufficiency, along with growing patient preference for minimally invasive day-care procedures over traditional vein stripping surgery.
According to the Journal of Vascular Surgery, recent meta-analyses through 2026 show radiofrequency ablation delivers fewer complications, including paresthesia, burns, and ecchymosis, compared with endovenous laser ablation while maintaining 93 to 94 percent saphenous vein occlusion at one year. The findings continue reshaping clinical preference and reinforce competitive innovation across the global endovenous ablation devices market.
According to the US FDA 510(k) clearance, InVera Medical received approval for its infusion device designed for the minimally invasive treatment of chronic venous disease, including varicose veins. The clearance supports the growing clinical shift toward non-thermal treatment technologies and strengthens innovation across the varicose vein treatment devices market.
According to Endovascular Today, emerging non-thermal endovenous treatment options including cyanoacrylate glue ablation and steam techniques continued expanding clinical adoption in early 2026, complementing established radiofrequency and laser ablation procedures. The diversification of treatment modalities reinforces accelerating innovation, premiumization, and competitive positioning across the global endovenous ablation devices market amid rising prevalence of chronic venous insufficiency.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
10.2%
Value in USD Billion
2026-2035
*this image is indicative*
Endovenous ablation devices are catheter-based tools used to close diseased superficial leg veins in patients with chronic venous insufficiency and varicose veins, using laser, radiofrequency, or non-thermal energy under ultrasound guidance. The market growth is driven by ageing populations, rising obesity, and broad insurance coverage for minimally invasive vein procedures. The market was valued at USD 1.12 Billion in 2025 and is poised to grow at a CAGR of 10.20%. The growth is supported by single-use catheter platforms and adhesive-based, non-tumescent systems that improve patient comfort.
Rising Prevalence of Chronic Venous Insufficiency to Accelerate Market Expansion
The growing burden of chronic venous disease is the leading driver of demand for endovenous ablation devices. According to the American Venous Forum, around 25 million adults in the United States are affected by chronic venous insufficiency, with many cases progressing to varicose veins and venous ulcers. This rising patient pool, coupled with increasing adoption of minimally invasive treatment approaches and improved clinical decision support technologies, is expected to significantly propel market growth over the forecast period.
A key trend in the market is the advancement of minimally invasive and non-thermal ablation technologies, enhancing treatment efficiency, patient comfort, and procedural outcomes.
Increasing Advancement of Non-Thermal Catheter Technologies is Likely to Boost the Market Demand
The market is witnessing the advancement of non-thermal catheter-based technologies that improve procedural safety and patient comfort. In April 2026, InVera Medical received US FDA 510(k) clearance for its novel infusion device designed to enhance sclerosant delivery and treatment efficiency. Such innovations address limitations of traditional thermal approaches, supporting wider adoption of minimally invasive procedures and contributing significantly to overall market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Indications
Market Breakup by End User
Market Breakup by Region
The market is segmented by indications into varicose veins, chronic venous insufficiency, spider veins, and others. Among these, the varicose veins segment is expected to lead due to its high prevalence and increasing treatment adoption. According to Jae Ho Chung et al., 2024, prevalence ranges from 1% to 73% in women and 2% to 56% in men, with Korea reporting a 5.4% annual rise in treated cases. This sustained demand is expected to strengthen segment growth over the forecast period.
North America is expected to dominate the market, supported by high chronic venous disease prevalence, advanced reimbursement frameworks, and a large network of office-based vein clinics. The growth is further driven by a high prevalence of chronic venous disorders, strong reimbursement frameworks, and widespread availability of advanced treatment options. Europe follows with steady growth due to increasing awareness and established healthcare systems, while the Asia Pacific is anticipated to witness rapid expansion owing to improving healthcare access and rising patient demand.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
AngioDynamics, Inc. is a key participant in the endovenous ablation devices market, offering advanced laser-based solutions for varicose vein treatment. Its VenaCure EVLT System, including the 1470 Pro Laser and NeverTouch Fiber, delivers high vein closure rates and precise energy targeting. The company supports minimally invasive, office-based procedures, strengthening its position in thermal ablation technologies and clinical adoption.
Medtronic plc is a leading medical technology company actively involved in the endovenous ablation devices market. The company offers advanced radiofrequency ablation systems, including endovenous catheters designed for minimally invasive treatment of varicose veins. Through continuous innovation and clinical studies, Medtronic strengthens its position in vein care by improving procedural efficiency, patient outcomes, and expanding the adoption of thermal ablation techniques.
Teleflex, headquartered in Wayne, Pennsylvania, supplies vascular access and interventional disposables that support endovenous ablation procedures, including introducer sheaths and ultrasound-guided access kits. The company maintains a footprint across more than 150 countries and continues investing in single-use procedure-pack solutions for office-based vein clinics globally.
Sciton, headquartered in Palo Alto, California, supplies the ProV laser platform used in endovenous laser ablation procedures for varicose vein treatment. The company focuses on dermatology and aesthetic vascular applications, supplying clinics across more than 80 countries, and continues investing in modular, multi-wavelength laser systems for vein specialists.
Other key players in the market are Merit Medical Systems, Inc., Venclose, Inc., Biolitec® Holding GmbH & Co. KG, Eufoton S.r.l., RF Medical Co., Ltd., and Boston Scientific Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share